搜尋





搜尋





市場行情
/
股票
/
avir
/

Atea Pharmaceuticals Inc

AVIR

添加自選

4.810USD

+0.080+1.69%

收盤 07-27 16:00（美東）報價延遲15分鐘

384.93M總市值

虧損本益比TTM

Atea Pharmaceuticals Inc

4.810

+0.080+1.69%

概覽

財務

分析

公司

財務摘要利潤表資產負債表現金流量表

AVIR 利潤表

您可以在這裡找到Atea Pharmaceuticals Inc的年度或季度收入報告，以深入了解Atea Pharmaceuticals Inc的營運、管理效率和表現。

單季報

單季報+年報

單季報

年報

YOY

隱藏空白列

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2020Q2

FY2020Q1

FY2019Q4

FY2019Q3

FY2019Q2

FY2019Q1

營業總收入

----

-100.00%0.00

295.16%192.18M

--32.81M

--60.39M

--65.98M

--48.63M

----

營業收入

----

-100.00%0.00

295.16%192.18M

--32.81M

--60.39M

--65.98M

--48.63M

----

營業費用

26.98%48.01M

55.14%54.71M

46.79%45.45M

16.92%41.42M

23.74%37.81M

24.40%35.27M

0.99%30.97M

20.89%35.43M

-6.33%30.55M

4.70%28.35M

15.60%30.66M

2.26%29.31M

13.09%32.62M

-48.87%27.08M

0.31%26.52M

25.35%28.66M

67.53%28.84M

184.39%52.96M

180.21%26.44M

391.57%22.86M

340.33%17.22M

292.12%18.62M

150.38%9.44M

25.09%4.65M

64.84%3.91M

--4.75M

--3.77M

--3.72M

--2.37M

研發費用

45.09%41.13M

117.22%47.60M

91.91%38.23M

39.40%32.35M

54.72%28.35M

30.26%21.91M

10.32%19.92M

43.83%23.21M

-8.41%18.32M

14.30%16.82M

19.22%18.06M

-0.53%16.14M

22.72%20.00M

-62.99%14.72M

4.44%15.15M

47.98%16.22M

92.74%16.30M

787.37%39.77M

168.15%14.50M

356.18%10.96M

214.89%8.46M

28.46%4.48M

124.35%5.41M

-14.97%2.40M

86.01%2.69M

--3.49M

--2.41M

--2.83M

--1.44M

折舊攤銷及損耗

0.00%104.00K

-1.89%104.00K

141.86%104.00K

1385.71%104.00K

1414.29%106.00K

437.50%43.00K

0.00%7.00K

16.67%7.00K

40.00%7.00K

100.00%8.00K

75.00%7.00K

--6.00K

25.00%5.00K

0.00%4.00K

-20.00%4.00K

----

--4.00K

--5.00K

營業利潤

-26.98%-48.01M

-55.14%-54.71M

-46.79%-45.45M

-16.92%-41.42M

-23.74%-37.81M

-24.40%-35.27M

-0.99%-30.97M

-20.89%-35.43M

6.33%-30.55M

-4.70%-28.35M

-15.60%-30.66M

-2.26%-29.31M

-13.09%-32.62M

-119.45%-27.08M

-516.52%-26.52M

-176.37%-28.66M

-159.15%-28.84M

363.90%139.22M

167.48%6.37M

906.88%37.53M

1347.26%48.77M

731.94%30.01M

-150.38%-9.44M

-25.09%-4.65M

-64.84%-3.91M

---4.75M

---3.77M

---3.72M

---2.37M

淨非營業利息收入（費用）

利息收入

-47.35%2.62M

-42.20%3.30M

-40.83%3.71M

-33.84%4.39M

-27.61%4.97M

-26.42%5.71M

-20.18%6.28M

-9.12%6.64M

9.03%6.87M

38.76%7.76M

79.46%7.86M

576.20%7.30M

6327.55%6.30M

10862.75%5.59M

8167.92%4.38M

1976.92%1.08M

68.97%98.00K

466.67%51.00K

657.14%53.00K

420.00%52.00K

1.75%58.00K

-90.43%9.00K

-94.89%7.00K

-93.90%10.00K

-68.16%57.00K

--94.00K

--137.00K

--164.00K

--179.00K

特殊收入（費用）

----

94.12%-221.00K

98.19%-113.00K

100.68%78.00K

96.86%-1.23M

79.37%-3.76M

38.39%-6.24M

-93.81%-11.49M

-338.62%-39.25M

-42.12%-18.22M

-198.82%-10.12M

-63.01%-5.93M

32.87%-8.95M

28.92%-12.82M

135.92%10.24M

87.39%-3.64M

26.40%-13.33M

-92.64%-18.04M

-248.08%-28.52M

-438.88%-28.84M

-13317.04%-18.11M

---9.36M

---8.19M

---5.35M

---135.00K

----

--0.00

----

稅前利潤

-33.23%-45.39M

-54.98%-51.63M

-35.34%-41.85M

8.25%-36.95M

45.87%-34.07M

14.16%-33.32M

6.06%-30.93M

-44.20%-40.28M

-78.45%-62.94M

-13.14%-38.81M

-176.67%-32.92M

10.52%-27.93M

16.18%-35.27M

-128.30%-34.31M

46.14%-11.90M

-457.19%-31.21M

-237.00%-42.08M

486.91%121.23M

-25.38%-22.09M

187.45%8.74M

870.14%30.71M

543.74%20.66M

-385.19%-17.62M

-181.18%-9.99M

-81.85%-3.99M

---4.66M

---3.63M

---3.55M

---2.19M

所得稅

-75.37%50.00K

-3108.00%-6.77M

-13.27%196.00K

-14.81%207.00K

-12.12%203.00K

-35.53%225.00K

2.26%226.00K

-3.19%243.00K

17.26%231.00K

183.74%349.00K

105.77%221.00K

109.17%251.00K

--197.00K

-97.00%123.00K

-162.84%-3.83M

-98.33%120.00K

--0.00

--4.10M

--6.10M

--7.20M

----

除稅後利潤

-32.59%-45.44M

-33.76%-44.87M

-34.98%-42.05M

8.29%-37.16M

45.75%-34.27M

14.35%-33.54M

6.01%-31.15M

-43.78%-40.52M

-78.11%-63.17M

-13.75%-39.16M

-310.89%-33.14M

10.06%-28.18M

15.71%-35.47M

-129.40%-34.43M

71.39%-8.07M

-2136.06%-31.34M

-237.00%-42.08M

467.06%117.13M

-59.99%-28.19M

115.40%1.54M

870.14%30.71M

543.74%20.66M

-385.19%-17.62M

-181.18%-9.99M

-81.85%-3.99M

---4.66M

---3.63M

---3.55M

---2.19M

持續經營利潤

-32.59%-45.44M

-33.76%-44.87M

-34.98%-42.05M

8.29%-37.16M

45.75%-34.27M

14.35%-33.54M

6.01%-31.15M

-43.78%-40.52M

-78.11%-63.17M

-13.75%-39.16M

-310.89%-33.14M

10.06%-28.18M

15.71%-35.47M

-129.40%-34.43M

71.39%-8.07M

-2136.06%-31.34M

-237.00%-42.08M

467.06%117.13M

-59.99%-28.19M

115.40%1.54M

870.14%30.71M

543.74%20.66M

-385.19%-17.62M

-181.18%-9.99M

-81.85%-3.99M

---4.66M

---3.63M

---3.55M

---2.19M

歸属于母公司的淨利潤

-32.59%-45.44M

-33.76%-44.87M

-34.98%-42.05M

8.29%-37.16M

45.75%-34.27M

14.35%-33.54M

6.01%-31.15M

-43.78%-40.52M

-78.11%-63.17M

-13.75%-39.16M

-310.89%-33.14M

10.06%-28.18M

15.71%-35.47M

-129.40%-34.43M

71.39%-8.07M

-2136.06%-31.34M

-237.00%-42.08M

467.06%117.13M

-59.99%-28.19M

115.40%1.54M

870.14%30.71M

543.74%20.66M

-385.19%-17.62M

-181.18%-9.99M

-81.85%-3.99M

---4.66M

---3.63M

---3.55M

---2.19M

歸屬普通股東的淨利潤

-32.59%-45.44M

-33.76%-44.87M

-34.98%-42.05M

8.29%-37.16M

45.75%-34.27M

14.35%-33.54M

6.01%-31.15M

-43.78%-40.52M

-78.11%-63.17M

-13.75%-39.16M

-310.89%-33.14M

10.06%-28.18M

15.71%-35.47M

-129.40%-34.43M

71.39%-8.07M

-2136.06%-31.34M

-237.00%-42.08M

467.06%117.13M

-59.99%-28.19M

115.40%1.54M

870.14%30.71M

543.74%20.66M

-385.19%-17.62M

-181.18%-9.99M

-81.85%-3.99M

---4.66M

---3.63M

---3.55M

---2.19M

基本每股收益

-42.56%-0.57

-44.64%-0.57

-44.15%-0.53

7.74%-0.44

46.54%-0.40

15.39%-0.40

7.15%-0.37

-42.32%-0.48

-76.87%-0.75

-13.54%-0.47

-310.19%-0.40

10.21%-0.34

15.87%-0.43

-129.33%-0.41

71.54%-0.10

-2123.44%-0.38

-236.01%-0.51

462.54%1.41

-55.99%-0.34

115.03%0.02

853.05%0.37

534.64%0.25

-385.22%-0.22

-181.14%-0.12

-81.85%-0.05

---0.06

---0.04

---0.03

稀釋每股收益

-42.56%-0.57

-44.64%-0.57

-44.15%-0.53

7.74%-0.44

46.54%-0.40

15.39%-0.40

7.15%-0.37

-42.32%-0.48

-76.87%-0.75

-13.54%-0.47

-310.19%-0.40

10.21%-0.34

15.87%-0.43

-130.92%-0.41

71.54%-0.10

-2254.32%-0.38

-246.76%-0.51

433.57%1.34

-55.99%-0.34

114.12%0.02

797.93%0.34

534.64%0.25

-385.22%-0.22

-181.14%-0.12

-81.85%-0.05

---0.06

---0.04

---0.03

每股派息

--0.00

貨幣單位

--USD

審計意見

----

常見問題

如何在 TradingKey 上查看 Atea Pharmaceuticals Inc 的利潤表？



先看總營收，再依序查看營業成本、毛利、營業費用、營業利益、稅前淨利、淨利和每股盈餘（EPS）。營收反映公司的業務規模，而各項獲利和利潤率則體現公司能否有效地將營收轉化為獲利。

季度利潤表和年度利潤表有什麼區別？



季度利潤表反映公司在一個為期三個月的財務季度內的經營表現，年度損益表則彙總整個財年的業績。季度數據適合用於觀察近期發展勢頭和季節性變化，年度數據則更適合評估長期成長、獲利能力和業務週期。

利潤表頁面中的同比是什麼意思？



同比（即年增率，YoY）是指將某項財務指標與上年同期進行比較，例如將本季度營收與去年同一季度的營收進行對比。與去年同期比較的數據有助於投資者觀察成長趨勢，同時減少正常季節性變化對分析的影響。

分析 AVIR 股票時，哪些利潤表指標最重要？



重要的指標包括營收成長、毛利、毛利率、營業利益、營業利益率、淨利、每股盈餘、研發費用、銷售及管理費用以及所得稅費用。投資者通常會綜合分析這些指標，以判斷公司是否正在成長、有效控制成本並提升獲利能力。

Atea Pharmaceuticals Inc 全年的淨利潤是多少？



Atea Pharmaceuticals Inc 2025 財年淨利潤為 -158.35M。

Atea Pharmaceuticals Inc 上一季度的淨利潤是多少？



Atea Pharmaceuticals Inc 最近一個季度的淨利潤為 -45.44M。

Atea Pharmaceuticals Inc 年度營業利潤是多少？



Atea Pharmaceuticals Inc 2025 財年的營業利潤為 -179.40M。

每股收益與利潤表有什麼關係？



每股收益（EPS）通常以淨利潤除以流通在外的股份數量計算，用於衡量公司平均每股創造的利潤。分析 EPS 時，還應結合股本變化、利潤率、現金流和估值指標進行綜合判斷。